Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
International Archives of Allergy and Immunology
|
May 1, 1996
Cetirizine exerts anti-inflammatory effects on human neutrophils
M Köller, R A Hilger, J P Rihoux, et al.
Die Pharmazie
|
August 9, 2013
Defining the role of MRP-mediated efflux and glutathione in detoxification of oxaliplatin
C Mohn, H-G Häcker, R A Hilger, et al.
Veterinary and Comparative Oncology
|
February 18, 2015
Safety, tolerability and pharmacokinetic properties of the novel triazene TriN 2755 in tumour bearing dogs - a phase I study<sup>†</sup>
I Athanasiadi, C Geigy, R A Hilger, et al.
Bone Marrow Transplantation
|
April 1, 2003
Femoral head necrosis in three patients with relapsed ovarian cancer receiving high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation
P Bojko, R A Hilger, S G Ruehm, et al.
Cancer Chemotherapy and Pharmacology
|
June 15, 2000
Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer
R A Hilger, G Jacek, C Oberhoff, et al.
Oncology Research
|
January 1, 1997
Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cells
U Vanhoefer, W Voigt, R A Hilger, et al.
Cancer Chemotherapy and Pharmacology
|
July 8, 1998
Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors
R A Hilger, A Harstrick, W Eberhardt, et al.
British Journal of Cancer
|
December 22, 1999
Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines
U Vanhoefer, M R Müller, R A Hilger, et al.
British Journal of Cancer
|
May 29, 2008
Oxaliplatin-DNA adduct formation in white blood cells of cancer patients
A C Pieck, A Drescher, K G Wiesmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2008
Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: results from a phase I extension trial
H Richly, B Schultheis, I A Adamietz, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
International Archives of Allergy and Immunology
|
May 1, 1996
Cetirizine exerts anti-inflammatory effects on human neutrophils
M Köller, R A Hilger, J P Rihoux, et al.
Die Pharmazie
|
August 9, 2013
Defining the role of MRP-mediated efflux and glutathione in detoxification of oxaliplatin
C Mohn, H-G Häcker, R A Hilger, et al.
Veterinary and Comparative Oncology
|
February 18, 2015
Safety, tolerability and pharmacokinetic properties of the novel triazene TriN 2755 in tumour bearing dogs - a phase I study<sup>†</sup>
I Athanasiadi, C Geigy, R A Hilger, et al.
Bone Marrow Transplantation
|
April 1, 2003
Femoral head necrosis in three patients with relapsed ovarian cancer receiving high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation
P Bojko, R A Hilger, S G Ruehm, et al.
Cancer Chemotherapy and Pharmacology
|
June 15, 2000
Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer
R A Hilger, G Jacek, C Oberhoff, et al.
Oncology Research
|
January 1, 1997
Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cells
U Vanhoefer, W Voigt, R A Hilger, et al.
Cancer Chemotherapy and Pharmacology
|
July 8, 1998
Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors
R A Hilger, A Harstrick, W Eberhardt, et al.
British Journal of Cancer
|
December 22, 1999
Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines
U Vanhoefer, M R Müller, R A Hilger, et al.
British Journal of Cancer
|
May 29, 2008
Oxaliplatin-DNA adduct formation in white blood cells of cancer patients
A C Pieck, A Drescher, K G Wiesmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2008
Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: results from a phase I extension trial
H Richly, B Schultheis, I A Adamietz, et al.
Page
of 3